William Blair Reiterates Outperform Rating on ARS Pharmaceuticals Inc (SPRY) Nov 10, 2025 07:29AM
ARS Pharmaceuticals to Participate in Upcoming Investor Conferences May 27, 2025 08:00AM
William Blair Upgrades ARS Pharmaceuticals Inc (SPRY) to Outperform, 'Sets Up Second Half 2024 Approval and Launch' Feb 20, 2024 11:53AM
William Blair Starts ARS Pharmaceuticals Inc (SPRY) at Outperform Jan 3, 2023 07:25AM